Full List Of Stories
Shire hopes to get green light for US Flexbumin manufacture
Shire on Thursday filed a submission to the US food and drug administration to gain approval to manufacture Flexbumin at its new facility in the state of Georgia.
FTSE 250 movers: Just Group soars on regulatory news as Hastings crashes
London's FTSE 250 was down 0. 22% to 18,447. 42 in afternoon trade on Thursday, as Just Group and Kaz Minerals led the gains.
Russia blocks UK's proposed post-Brexit trade quotas
Russia and a number of other members of the World Trade Organisation have moved to block Britain from inheriting the terms it held with the organisation under the EU.
UBS upgrades CYBG but still prefers the bigger banks
UBS upgraded its outlook on CYBG from ‘sell’ to ‘neutral’ on Thursday after the banking company’s shares dropped 21% throughout October.
Orders piling up for Eckoh's US and UK businesses
Call centre software specialist Eckoh reported on Thursday that contract value from its US and UK secure payments divisions in the first half has already exceeded the last full year.
Skinbio begins human studies of moisturising cream
The past year has seen SkinBioTherapeutics make “significant progress” with the development of its moisturising cream and efforts to begin human trials, the company said on Thursday.